RGD-conjugated Nanoparticles for Targeted Inhibition of Metastasis of Integrin αvβ3-overexpressing Breast Cancer Cells
Year: 2013
Type: dissertation
Abstract: The use of actively targeted nanoparticles as a delivery system for both the diagnosis and treatment of cancer has been explored extensively. However, selective tumor accumulation is not guaranteed. The objectives of this thesis were 1) to optimize the nanoparticle surface content of cyclic arginyl-glycyl-aspartic acid (cRGD) decorated solid lipid nanoparticles (RGD-SLN) in targeting αvβ3 integrin receptor, and 2) to evaluate the potential of RGD-SLN in inhibition of metastasis. Nanoparticles of cRGD content ranging from 0 – 10% mol were synthesized. They showed enhanced binding for αvβ3 integrin receptors and increased cellular uptake in the breast cancer cells. In vitro treatment with RGD-SLNs reduced tumor cell adhesion and invasion. Maximum tumor accumulation was demonstrated in 1% mol of RGD on the nanoparticle surface among all formulations tested in vivo. This work has laid a foundation for further development of anticancer drug-loaded cRGD-nanoparticle formulations useful for the treatment of breast cancer metastasis.
Source: TSpace (University of Toronto)
Author: Dan Shan
Institution: University of Toronto
Language: English
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W2565948998
